MARY METZ: Open Payments
NPI 1952065906 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,692 in 73 payments from 25 companies in 2025. Trend: 2023 $588 · 2024 $1,498 · 2025 $10,692
Speaker / faculty: $7,625Food & beverage: $1,659Consulting: $1,350Travel & lodging: $59
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $9,308 |
| ABBVIE INC. | 16 | $394 |
| Lundbeck LLC | 3 | $195 |
| UCB, Inc. | 4 | $112 |
| ACADIA Pharmaceuticals Inc | 3 | $72 |
| Merz Pharmaceuticals, LLC | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| EMD Serono, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Tonix Medicines, Inc. | 2 | $38 |
Products named: NURTEC ODT, QULIPTA, VYEPTI, UBRELVY, NUPLAZID, OCTAGAM IMMUNE GLOBULIN (HUMAN), Xeomin, KESIMPTA.
Industry payments across NE — which companies pay providers there.
